Inhibition of microbiota-dependent TMAO production attenuates chronic kidney disease in mice

Abstract Patients with chronic kidney disease (CKD) have elevated circulating levels of trimethylamine N-oxide (TMAO), a metabolite derived from gut microbes and associated with cardiovascular diseases. High circulating levels of TMAO and its dietary precursor, choline, predict increased risk for de...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Wenchao Zhang, Aika Miikeda, Jonathan Zuckerman, Xun Jia, Sarada Charugundla, Zhiqiang Zhou, Karolina Elżbieta Kaczor-Urbanowicz, Clara Magyar, Fangfei Guo, Zeneng Wang, Matteo Pellegrini, Stanley L. Hazen, Susanne B. Nicholas, Aldons J. Lusis, Diana M. Shih
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2021-01-01
coleção:	Scientific Reports
Acesso em linha:	https://doi.org/10.1038/s41598-020-80063-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!